Respiratory Final Presentation

download Respiratory Final Presentation

of 158

Transcript of Respiratory Final Presentation

  • 7/28/2019 Respiratory Final Presentation

    1/158

    P R E P A R E D B Y :

    M A R I S O L J A N E T . J O M A Y A

    I N S T R U C T O R

    THE RESPIRATORY SYSTEM

  • 7/28/2019 Respiratory Final Presentation

    2/158

    L A B O R A T O R Y A S S E S S M E N T

    Diagnosis of Pulmonary

    Function

  • 7/28/2019 Respiratory Final Presentation

    3/158

    Routine Radiography

    Integral part of the diagnostic evaluation ofdiseases involving the pulmonary

    parenchyma, the pleura, and to a lesser extent,the airways and the mediastinum.

    Usually involves a postero-anterior view and alateral view.

    Lateral decubitus views are often useful fordetermining whether pleural deformitiesrepresent freely flowing fluid.

  • 7/28/2019 Respiratory Final Presentation

    4/158

    Chest Radiography

  • 7/28/2019 Respiratory Final Presentation

    5/158

    Computed Tomography

    Offers several advantages over conventionalradiographs.

    Use of cross-sectional images makes itpossible to distinguish between densities.

    Better at characterizing tissue densities andproviding accurate size of lesions.

  • 7/28/2019 Respiratory Final Presentation

    6/158

    Computed Tomography

  • 7/28/2019 Respiratory Final Presentation

    7/158

    Computed Tomography

  • 7/28/2019 Respiratory Final Presentation

    8/158

    Magnetic Resonance Imaging

  • 7/28/2019 Respiratory Final Presentation

    9/158

    Pulmonary Function Tests

    Objectively measure the ability of therespiratory system to perform gas exchange by

    assessing ventilation, diffusion andmechanical properties.

    Composed of the spirometry test andventilation-perfusion (V/Q) test.

  • 7/28/2019 Respiratory Final Presentation

    10/158

    Pulmonary Function Tests

    Indications:

    Evaluation of the type and degree of pulmonarydysfunction (obstructive or restrictive)

    Evaluation of dyspnea, cough and other symptoms Early detection of lung dysfunction

    Surveillance in occupational settings

    Follow-up or response to therapy

    Preoperative evaluation

    Disability assessment

  • 7/28/2019 Respiratory Final Presentation

    11/158

    Pulmonary Function Tests

    Spirometry Allows for the

    determination of thepresence and severity ofobstructive and restrictive

    pulmonary dysfunction. The hallmark of

    obstructive pulmonarydysfunction is reduction ofairflow rates.

    Restrictive pulmonarydysfunction ischaracterized by reductionin pulmonary volumes.

  • 7/28/2019 Respiratory Final Presentation

    12/158

    Pulmonary Function Tests

    Ventilation-PerfusionLung Scan (V/Q scan)

    Measures the degree ofventilation of the individual

    lung segments and theperfusion of respectivesegments to detect anyshunting or mismatch.

    Finds utility in settingswhere possible pulmonaryembolism is suspected.

  • 7/28/2019 Respiratory Final Presentation

    13/158

  • 7/28/2019 Respiratory Final Presentation

    14/158

    Arterial Blood Gases

    Measure of acid andbase balance in theblood.

    Also check thesaturation of blood withoxygen.

  • 7/28/2019 Respiratory Final Presentation

    15/158

    Biologic Specimen Collection

    Sputum collection

    Spontaneous expectorationor sputum induction

    Percutaneous needleaspiration

    Usually carried out underCT or ultrasound guidance.

    Potential risks includeintrapulmonary bleedingand creation of apneumothorax.

  • 7/28/2019 Respiratory Final Presentation

    16/158

    Biologic Specimen Collection

    Thoracentesis

    Sampling of pleuralfluid or for palliation ofdyspnea in patients with

    pleural effusion.

    Analysis of the fluid forcellular compositionand chemical

    constituents likeglucose, protein andLDH.

  • 7/28/2019 Respiratory Final Presentation

    17/158

    Biologic Specimen Collection

    Bronchoscopy Provides for direct

    visualization of thetracheobronchial tree.

    Rigid bronchoscopy is

    performed in an operatingroom on a patient undergeneral anesthesia.

    Flexible bronchoscopy maybe done under localanesthesia / sedation.

    Diagnostic uses includehistologic identification orneoplasms and identificationof sources of hemoptysis.

  • 7/28/2019 Respiratory Final Presentation

    18/158

    Bronchoscopy

    Therapeuticindications areretrieval of foreignbodies and control

    of bleeding. Bronchoalveolar

    lavage has beenused for the

    recovery oforganisms that aredifficult to isolate inthe usual sputumrecovery methods.

  • 7/28/2019 Respiratory Final Presentation

    19/158

  • 7/28/2019 Respiratory Final Presentation

    20/158

    N E O N A T A L

    C H I L D

    Y O U N G A D U L T

    A C R O S S T H E L I F E S P A N

    Diseases of the Respiratory

    System

  • 7/28/2019 Respiratory Final Presentation

    21/158

    CHOANAL ATRESIA

    Choanal atresia iscongenital obstructionof the posterior nares byan obstructingmembrane or bonygrowth, preventing anewborn from drawing

    air through the nose anddown into thenasopharynx.

  • 7/28/2019 Respiratory Final Presentation

    22/158

    CHOANAL ATRESIA

    ASSESSMENT

    Signs of respiratory distress at birth or immediatelyafter they quiet for the first time and attempt to

    breathe through their nose. Failure of the catheter to pass bilaterally through the

    nares to the stomach immediately after birth.

    Air hunger when mouth is closed color improves

    when mouth opens Cyanosis at feedings because the baby cannot suck

    and breath through the mouth simultaneously

  • 7/28/2019 Respiratory Final Presentation

    23/158

    CHOANAL ATRESIA

  • 7/28/2019 Respiratory Final Presentation

    24/158

    CHOANAL ATRESIA

    Management and Treatment

    Local piercing of the obstructing membrane

    Surgical removal of the bony growth.

    Intravenous fluid to maintain their glucose and fluidlevel until surgery can be performed.

    Oral airway inserted so they can continue to breathethrough their mouths.

    Following surgery, children have no further difficultyor symptoms.

  • 7/28/2019 Respiratory Final Presentation

    25/158

    LARYNGOTRACHEOBRONCHITIS (LTB)

    ACUTELARYNGOTRACHEOBRONCHITIS (LTB)ANDSPASMODIC CROUP

    Acute LTB is characterizedby inflammation andnarrowing of the laryngealand tracheal areas. It isthe most common form of

    croup and usually affectschildren younger than 5

    years old

  • 7/28/2019 Respiratory Final Presentation

    26/158

    LARYNGOTRACHEOBRONCHITIS (LTB)

    Spasmodic croup is similar to acute LTB, but it tendsto occur at night and recurs with respiratory tractinfection

    Acute LTB is usually caused by virus Spasmodic croup is not caused by a virus, but may

    have associated genetic, allergic, or emotionalpredisposing factors

  • 7/28/2019 Respiratory Final Presentation

    27/158

    LARYNGOTRACHEOBRONCHITIS (LTB)

    Acute LTB Gradual onset from URTI,

    which progresses to signs ofdistress

    Hoarseness Inspiratory stridor

    Retractions

    Severe respiratory distress

    Low-grade fever Restlessness and irritability

    Wheezing

  • 7/28/2019 Respiratory Final Presentation

    28/158

    LARYNGOTRACHEOBRONCHITIS (LTB)

    Spasmodic croup

    Is characterized by S/S similar to acute LTB, but thechild is afebrile, the onset is sudden, and the child isawakened at night with a barklike cough

  • 7/28/2019 Respiratory Final Presentation

    29/158

    INTERVENTIONS

    Assess respiratory status, monitoring for nasal flaring,sternal retraction, and inspiratory stridor.

    Monitor for pallor or cyanosis.

    Elevate the head of the bed and provide bed rest.

    Assesses for airway obstruction

    Keep emergency equipment near the bedside

    Administer oxygen and increase atmospheric humidity

    Promote desired fluid intake Administer prescribed medications

    Minimize fear and anxiety

  • 7/28/2019 Respiratory Final Presentation

    30/158

    INTERVENTIONS

    Provide humidified oxygenvia cool-mist tent for thehospitalized child.

    Instruct the parents to use

    a cool-air vaporizer orhumidifier at home; othermeasures include havingthe child breathe in thecool night air or the air

    from an open freezer ortaking the child to a cool

    basement or garage.

  • 7/28/2019 Respiratory Final Presentation

    31/158

    BRONCHIOLITIS

    is a disorder most commonly caused in infantsbyviral lower respiratory tract infection.

    It is the most commonlower respiratory infection

    in this age group. It is the inflammation of thebronchioles, the

    smallest air passages of the lungs.

    It is characterizedby acute inflammation, edema,

    and necrosis of epithelial cells lining small airways,increased mucus production, and bronchospasm.

    http://en.wikipedia.org/wiki/Bronchiolehttp://en.wikipedia.org/wiki/Bronchiole
  • 7/28/2019 Respiratory Final Presentation

    32/158

    BRONCHIOLITIS

    Causes - most commonly

    caused byrespiratorysyncytial virus (RSV, alsoknown as human

    pneumovirus). - Other viruses

    which may cause thisillness include

    meta pneumovirus,influenza, parainfluenza,coronavirus, adenovirusand rhinovirus.

  • 7/28/2019 Respiratory Final Presentation

    33/158

    BRONCHIOLITIS

    Signs and symptoms are typically rhinitis,

    tachypnea, wheezing, cough, crackles, use ofaccessory muscles,and/or nasal flaring

    Treatment There is no effective specific treatment for

    bronchiolitis. Therapy is principally supportive.

  • 7/28/2019 Respiratory Final Presentation

    34/158

    INTERVENTIONS

    Conservative measures Frequent small feeds are encouraged to maintain

    hydration as evidenced by good urine output, andsometimes oxygen may be required to maintain bloodoxygen levels.

    Suction of the nasopharynx is often performed tomaintain a clear airway.

    In severe cases the infant may need to be fed via anasogastric tube or it may even need intravenous fluids.

    In extreme cases, mechanical ventilation might benecessary. Bronchodilators Handwashing/Immunization (PALIVIZUMAB)

    http://en.wikipedia.org/wiki/Nasopharynxhttp://en.wikipedia.org/wiki/Nasogastric_tubehttp://en.wikipedia.org/wiki/Nasogastric_tubehttp://en.wikipedia.org/wiki/Nasogastric_tubehttp://en.wikipedia.org/wiki/Nasogastric_tubehttp://en.wikipedia.org/wiki/Nasopharynx
  • 7/28/2019 Respiratory Final Presentation

    35/158

  • 7/28/2019 Respiratory Final Presentation

    36/158

    TONSILLITIS

    Tonsillitis is aninfection (usuallyviral) of the tonsils

    If a child has many

    infections, the tonsilsare surgicallyremoved

  • 7/28/2019 Respiratory Final Presentation

    37/158

    TONSILLITIS

    It is believed thattonsils help preventbacteria and other

    pathogens fromentering the bodytherefore a removalmay increase the

    number of illnesseslater in life

  • 7/28/2019 Respiratory Final Presentation

    38/158

    TONSILLITIS

    CAUSES In tonsillitis, structures that are already large become

    inflamed due to an infectious agent and cause airway

    obstruction, decreased appetite, and pain.

    Infection is caused by bacterial or viral organisms, withviral organisms most commonly implicated.

    Group A beta-hemolytic Streptococcus is the most

    common bacterial cause.

  • 7/28/2019 Respiratory Final Presentation

    39/158

    TONSILLITIS

    CLINICAL MANIFESTATIONS

    OBSTRUCTIVE SLEEP APNEA

    LOUDSNORINGORNOISYBREATHINGINSLEEP EXCESSIVEDAYTIMESLEEPINESS

    MOUTHBREATHING

  • 7/28/2019 Respiratory Final Presentation

    40/158

    TONSILLITIS

    CHRONIC INFECTIONOF TONSILS

    MOUTHBREATHINGORDIFFICULTYBREATHING

    FREQUENTSORETHROAT

    ANOREXIA, DECREASEDGROWTHVELOCITY FEVER

    OBSTRUCTIONTOSWALLOWING/BREATHING

    NASAL, MUFFLEDVOICE NIGHTCOUGH

    OFFENSIVEBREATH

  • 7/28/2019 Respiratory Final Presentation

    41/158

    Diagnostic Evaluation

    Thorough ears, nose, and throat examination andappropriate cultures to determine presence and

    source of infection; Preoperative blood studies to determine risk of

    bleeding-clotting time, smear for platelets,prothrombin time, partial thromboplastin time

  • 7/28/2019 Respiratory Final Presentation

    42/158

  • 7/28/2019 Respiratory Final Presentation

    43/158

    SURGICAL MANAGEMENT

    INDICATIONSFORTONSILLECTOMY

    RECURRENTORPERSISTENTTONSILLITISWITHDOCUMENTEDSTREPTOCOCCALINFECTIONFOURTIMESIN

    1YEAR

    MARKEDHYPERTROPHYOFTONSILS,WHICHDISTORTS

    SPEECHCAUSESSWALLOWINGDIFFICULTIES,ANDCAUSESSUBSEQUENTWEIGHTLOSS

    TONSILLARMALIGNANCY

  • 7/28/2019 Respiratory Final Presentation

    44/158

    Treatment - tonsillectomy

  • 7/28/2019 Respiratory Final Presentation

    45/158

    INTERVENTIONS

    Reducing fear Relieving parental anxiety Assess frequently for

    bleeding postoperatively.Check all secretions andemesis for presence of fresh

    blood.

    Indications of hemorrhageinclude the following: Increased pulse Frequent swallowing Pallor

    Restlessness Clearing of throat and

    vomiting ,of blood Continuous slight oozing of

    blood over a number of

    hours Oozing of blood in back of

    throat

  • 7/28/2019 Respiratory Final Presentation

    46/158

    INTERVENTIONS

    HAVESUCTIONEQUIPMENTANDPACKINGMATERIALREADILYAVAILABLEINCASEOFEMERGENCY.

    PROVIDEADEQUATEFLUIDINTAKE.

    GIVEICECHIPS 1 TO 2 HOURSAFTERAWAKENINGFROMANESTHESIA.

    WHENVOMITINGHASCEASED,ADVANCETOCLEARLIQUIDCAUTIOUSLY.

  • 7/28/2019 Respiratory Final Presentation

    47/158

    INTERVENTIONS

    OFFERCOOLFRUITJUICESWITHOUTPULPATFIRSTBECAUSETHEYAREBESTTOLERATED; THENOFFERPOPSICLES, COOLWATERFORFIRST 12 TO 24 HOURS.

    AVOIDRED/BROWNFLUIDS.

    THEREISSOMECONTROVERSYREGARDINGINTAKEOFMILKANDICECREAMTHEEVENINGOFSURGERY.

    EXPLAINANDWRITEINSTRUCTIONSCONCERNINGTHECAREOFTHECHILDATHOMEAFTERDISCHARGE.

    DIETSHOULDSTILLCONSISTOFLARGEAMOUNTSOFFLUIDSANDSOFT, COOL, NONIRRITATINGFOODS.(SUPPLYLISTOFSUGGESTIONS.)

  • 7/28/2019 Respiratory Final Presentation

    48/158

    INTERVENTIONS

    EATINGHELPSPROMOTEHEALINGBECAUSEITINCREASESTHEBLOODSUPPLYTOTISSUES.

    BEDRESTSHOULDBEMAINTAINEDFOR1 TO 2 DAYSANDTHENDAILYRESTPERIODSFORABOUT 1WEEK. RESUME

    NORMALEATINGANDACTIVITIESWITHIN 2WEEKSAFTERSURGERY.

    AVOIDCONTACTWITHPEOPLEWITHINFECTIONS.

    DISCOURAGETHECHILDFROMFREQUENTCOUGHINGANDCLEARINGOFTHROAT.

    AVOIDGARGLING. MOUTHODORMAYBEPRESENTFORAFEWDAYSAFTERSURGERY; ONLYMOUTHRINSINGISACCEPTABLE.

  • 7/28/2019 Respiratory Final Presentation

    49/158

    LARYNGITIS

    Laryngitis is aninflammation of thelarynx (vocal cords)

    CAUSES: virus

    allergiesstraining

    of voice

  • 7/28/2019 Respiratory Final Presentation

    50/158

    LARYNGITIS

    When the larynx is inflamed, the vocal cordscant vibrate properly therefore the voice ishoarse or even non-existent

    TREATMENT rest, fluids, no talking!!

    i f i

  • 7/28/2019 Respiratory Final Presentation

    51/158

    Upper Respiratory Tract Infections:Common Cold (Infectious Rhinitis)

    Viral (rhinovirus) Spread through respiratory droplets Highly contagious Initially mucous membranes of nose,

    pharynx swollen, increased secretions Signs Nasal congestion and watery discharge Mouth breathing

    Change in tone of voice Sore throat, headache, slight fever Cough

  • 7/28/2019 Respiratory Final Presentation

    52/158

    COMMON COLD

    Treatment rest,fluids NOTantibiotics it is a

    virus Presently, there is

    no cure or vaccine

  • 7/28/2019 Respiratory Final Presentation

    53/158

    COMMON COLD

    The cold virus isspread eitherthrough droplets inthe air or direct

    contact with aninfected person orcontaminated surface(1 day before

    symptoms appearand up to 5 daysafter)

    The best way to reduce the chances

    http://en.wikipedia.org/wiki/Image:Aerosol_from_Sneeze.jpg
  • 7/28/2019 Respiratory Final Presentation

    54/158

    The best way to reduce the chancesof getting a cold

    WASH HANDS!

  • 7/28/2019 Respiratory Final Presentation

    55/158

    CYSTIC FIBROSIS

    Genetic condition An abnormal gene

    causes the cells liningthe alveoli to secrete

    a thick, sticky mucus Mucus attracts

    bacteria andnumerous infections

    result

  • 7/28/2019 Respiratory Final Presentation

    56/158

    CYSTIC FIBROSIS - treatments

    There is no cure lifeexpectancy is usuallylow early 30s

    Medicines are used to

    thin the mucus Antibiotics are given

    for infections

  • 7/28/2019 Respiratory Final Presentation

    57/158

  • 7/28/2019 Respiratory Final Presentation

    58/158

  • 7/28/2019 Respiratory Final Presentation

    59/158

  • 7/28/2019 Respiratory Final Presentation

    60/158

  • 7/28/2019 Respiratory Final Presentation

    61/158

    Diagnostic Tests Pilocarpine iontophoresis sweat

    chloride test

    Pulmonary function tests

    ABG and oxygen saturation levels

  • 7/28/2019 Respiratory Final Presentation

    62/158

    Quantitative Sweat Chloride Test The production of sweat is stimulated (pilocarpine

    iontophoresis), the sweat is collected, and thesweat/electrolytes are measured (a minimum of 50mg of is needed).

    Normally, sweat chloride concentration is less thanpositive test result.

    Chloride concentrations of 40 to 60 mEq/L arehighly suggestive of cystic fibrosis and require arepeat test.

  • 7/28/2019 Respiratory Final Presentation

    63/158

    Medications Immunizations against respiratory infections,

    influenza vaccine

    Bronchodilators Antibiotics

    Dornase alfa, as aerosol breaks down excess DNA insputum

  • 7/28/2019 Respiratory Final Presentation

    64/158

    INTERVENTIONS

    RESPIRATORYSYSTEM GOALSOFTREATMENTINCLUDEPREVENTINGAND

    TREATINGPULMONARYINFECTIONBYIMPROVINGAERATION, REMOVINGSECRETIONS,ANDADMINISTERINGANTIMICROBIALMEDICATIONS.

    CHESTPHYSIOTHERAPY(PERCUSSIONANDPOSTURALDRAINAGE) ONAWAKENINGANDINTHEEVENING (MORE

    FREQUENTLYDURINGPULMONARYINFECTION). CHESTPHYSIOTHERAPYSHOULDNOTBEPERFORMED

    BEFOREORIMMEDIATELYAFTERAMEAL.

  • 7/28/2019 Respiratory Final Presentation

    65/158

    ILLUSTRATIONS FORPOSTURAL DRAINAGE

    UPPER LOBES FRONT

    ILLUSTRATIONS FORPOSTURAL DRAINAGE

    UPPER LOBES BACK

    O S

  • 7/28/2019 Respiratory Final Presentation

    66/158

    INTERVENTIONS

    BRONCHODILATORMEDICATIONBYAEROSOLOPENSTHEBRONCHIFOREASIEREXPECTORATION (ADMINISTEREDBEFORETHECHESTPHYSIOTHERAPYWHENTHECHILDHASREACTIVEAIRWAYDISEASEORISWHEEZING).

    ADMINISTRATIONOFRECOMBINANTHUMANDEOXYRIBONUCLEASE

    (DNASE), KNOWNGENERICALLYASDORNASEALFA(PULMOZYME),WHICHDECREASESTHEVISCOSITYOFMUCUS.

  • 7/28/2019 Respiratory Final Presentation

    67/158

    INSTRUCTTHEPARENTSNOTTOGIVECOUGHSUPPRESSANTS, FORTHEYWILLINHIBITEXPECTORATIONOFSECRETIONSANDPROMOTEINFECTION.

    TEACHTHECHILDFORCEDEXPIRATORYTECHNIQUE(HUFFING) TOMOBILIZESECRETIONS.

  • 7/28/2019 Respiratory Final Presentation

    68/158

    DEVELOPAPHYSICALEXERCISEPROGRAMWITHTHEAIMOFESTABLISHINGAGOODHABITUALBREATHINGPATTERN.

    ADMINISTERANTIBIOTICSASPRESCRIBED,WHICHMAYBEPRESCRIBEDPROPHYLACTICALLYORWHENPULMONARYSYMPTOMSDEVELOP.

    ADMINISTEROXYGENASPRESCRIBEDDURINGACUTE

    EPISODES; MONITORCLOSELYFOROXYGENNARCOSIS.

  • 7/28/2019 Respiratory Final Presentation

    69/158

    MONITORFORHEMOPTYSIS; GREATERTHAN 300 MLIN 24 HOURSFORTHEOLDERCHILD (LESSFORA

    YOUNGERCHILD) NEEDSTOBETREATEDIMMEDIATELY.

    HEMOPTYSISMAYBECONTROLLEDBYBEDREST,COUGHSUPPRESSANTS,ANTIBIOTICS,ANDVITAMINK; IFHEMOPTYSISPERSISTS, THESITEOFBLEEDINGMAYBECAUTERIZEDOREMBOLIZED.

    LUNGTRANSPLANTATIONISAFINALTHERAPEUTICOPTIONFORTHECHILDWITHEND-STAGEDISORDER.

    INTERVENTIONS

  • 7/28/2019 Respiratory Final Presentation

    70/158

    INTERVENTIONS

    GASTROINTESTINALSYSTEM THEGOALOFTREATMENTFORPANCREATIC

    INSUFFICIENCYISTOREPLACEPANCREATICENZYMES;ADMINISTEREDWITHMEALSANDSNACKS (ORWITHIN

    30 MINUTESOFEATINGMEALSANDSNACKS) TOENSURETHATDIGESTIVEENZYMESAREMIXEDWITHFOODINTHEDUODENUM.

    THEAMOUNTOFPANCREATICENZYMESADMINISTERED

    ISADJUSTEDTOACHIEVENORMALGROWTHANDADECREASEINTHENUMBEROFSTOOLSTOTWOORTHREEPERDAY.

    INTERVENTIONS

  • 7/28/2019 Respiratory Final Presentation

    71/158

    INTERVENTIONS

    ENTERIC-COATEDPANCREATICENZYMESSHOULDNOTBECRUSHEDORCHEWED.

    PANCREATICENZYMES

    SHOULDNOTBEGIVENIFTHECHILDISTORECEIVENOTHINGBYMOUTH.

    ENCOURAGEAWELL-BALANCED, HIGH-

    PROTEIN, HIGHCALORIEDIET; MULTIVITAMINSANDVITAMINS A, D E,AND KAREALSOADMINISTERED.

    INTERVENTIONS

  • 7/28/2019 Respiratory Final Presentation

    72/158

    INTERVENTIONS

    ASSESSWEIGHTANDMONITORFORFAILURETOTHRIVE. MONITORFORCONSTIPATIONANDINTESTINALOBSTRUCTION.

    ENSUREADEQUATESALTINTAKEDURINGEXTREMEHOTWEATHERORIFTHECHILDHASAFEVER; INCLUDEFLUIDSSUCHAS GATORADEOREXCEED,WHICHPROVIDEANADEQUATESUPPLYOFELECTROLYTES.

    CYSTIC FIBROSIS

  • 7/28/2019 Respiratory Final Presentation

    73/158

    CYSTIC FIBROSIS

    New treatmentsinclude gene therapy

    An inhaler is used tospray healthy

    versions of theabnormal gene thehealthy genes canthen make propermucus

    PULMOZYME

    NOSE FRACTURE

  • 7/28/2019 Respiratory Final Presentation

    74/158

    NOSE FRACTURE

    A fractured nose is the mostcommon facial fracture.

    It usually results from ablunt injury and is often

    associated with other facialfractures. The bruisedappearance usuallydisappears after 2 weeks.

    Nose injuries and neckinjuries are often seentogether

  • 7/28/2019 Respiratory Final Presentation

    75/158

    Serious nose injuriescause problems that

    require immediateprofessional attention.However, for minornose injuries, thedoctor may prefer to

    see the victim after theswelling subsides. Occasionally, plastic

    surgerymay benecessary to correct a

    deformity of the noseor nasal septum causedby a trauma.

    NOSE FRACTURE

  • 7/28/2019 Respiratory Final Presentation

    76/158

    NOSE FRACTURE

    First Aid Reassure the patient and try to keep the patient

    calm.

    Have the patientbreathe through the mouth and

    lean forward in a sitting position in order tokeep blood from going down the back of the throat.

    Applycold compresses to the nose to reduceswelling. If possible, the patient should hold the

    compress so that excessive pressure is not applied. To help relieve pain, acetaminophen is

    recommended.

    NOSE FRACTURE

  • 7/28/2019 Respiratory Final Presentation

    77/158

    NOSE FRACTURE

    DO NOT try to straighten a broken nose. DO NOT move the person if there is reason to

    suspect a head or neck injury.

    Call immediately for emergency medicalassistance if

    You suspect a neck or head injury

    Bleeding will not stop

    Clear fluid keeps draining from the nose

    The person is having difficulty breathing

    NOSE FRACTURE

  • 7/28/2019 Respiratory Final Presentation

    78/158

    NOSE FRACTURE

    Prevention Protective headgear should be worn while playing

    contact sports, riding bicycles, skateboards, roller-skates, or roller blades.

    Seat belts and appropriate car seats should be used.

    DEVIATED SEPTUM

  • 7/28/2019 Respiratory Final Presentation

    79/158

    DEVIATED SEPTUM

    Definition The nasal septum

    is a thin structure,separating the twosides of the nose.If it is not in themiddle of the nose,then it is deviated.

  • 7/28/2019 Respiratory Final Presentation

    80/158

    It is common for apatient to complainthat he/she can

    breathe through only

    one nostril. Then thediagnosis is easy.

    A deviated septummay also contribute

    to snoring, sleepapnea, and other

    breathing disorders.

  • 7/28/2019 Respiratory Final Presentation

    81/158

    As a palliative, saline drops and sprays are veryhelpful in loosening mucus in the obstructed side andpreventing drying in the other side, where all the air

    blows.

    Hot peppers, such as jalapenos, can produce enoughtears and discharge to flush out a stopped-up nose.

    An even more effective treatment is called a nasallavage, often done using a small pot with a spout.

    Nasospecific, a procedure where a deflated balloon is

    inserted in the nostril and inflated to a large enoughdegree to adjust the septal deviation, can be analternative to surgery.

  • 7/28/2019 Respiratory Final Presentation

    82/158

    Treatment The definitive treatment is surgical repositioning of

    the septum, accomplished by breaking it loose andfixing it in a proper place while it heals.

    Decongestants likepseudoephedrine orphenylpropanolamine will shrink the membranesand thereby enlarge the passages.

    Antihistamines, nasal cortisone spray, and otherallergy treatments may also be temporarily

    beneficial.

    NASAL POLYPS

  • 7/28/2019 Respiratory Final Presentation

    83/158

    NASAL POLYPS

    NASALPOLYPSAREPOLYPOIDALMASSESARISINGMAINLYFROMTHEMUCOUSMEMBRANESOFTHENOSEANDPARANASALSINUSES.THEYAREOVERGROWTHSOFTHEMUCOSATHATFREQUENTLYACCOMPANYALLERGICRHINITIS. THEYAREFREELYMOVEABLEANDNON-TENDER.

    NASAL POLYPS

    http://en.wikipedia.org/wiki/Polyp_(medicine)http://en.wikipedia.org/wiki/Mucous_membranehttp://en.wikipedia.org/wiki/Mucous_membranehttp://en.wikipedia.org/wiki/Mucous_membranehttp://en.wikipedia.org/wiki/Nosehttp://en.wikipedia.org/wiki/Paranasal_sinushttp://en.wikipedia.org/wiki/Paranasal_sinushttp://en.wikipedia.org/wiki/Paranasal_sinushttp://en.wikipedia.org/wiki/Allergic_rhinitishttp://en.wikipedia.org/wiki/Allergic_rhinitishttp://en.wikipedia.org/wiki/Allergic_rhinitishttp://en.wikipedia.org/wiki/Allergic_rhinitishttp://en.wikipedia.org/wiki/Allergic_rhinitishttp://en.wikipedia.org/wiki/Allergic_rhinitishttp://en.wikipedia.org/wiki/Paranasal_sinushttp://en.wikipedia.org/wiki/Paranasal_sinushttp://en.wikipedia.org/wiki/Paranasal_sinushttp://en.wikipedia.org/wiki/Nosehttp://en.wikipedia.org/wiki/Mucous_membranehttp://en.wikipedia.org/wiki/Mucous_membranehttp://en.wikipedia.org/wiki/Mucous_membranehttp://en.wikipedia.org/wiki/Polyp_(medicine)
  • 7/28/2019 Respiratory Final Presentation

    84/158

    NASAL POLYPS

    SYMPTOMS NASALBLOCK SINUSITIS ANOSMIAORLOSSOFSMELL

    SECONDARYINFECTIONLEADINGTOHEADACHE. CAUSE: UNKNOWNBUTARECOMMONLYTHOUGHTTOBECAUSEDBY ALLERGY ASIGNIFICANTNUMBERAREASSOCIATEDWITHNON-

    ALLERGICADULTASTHMAORNORESPIRATORYORALLERGICTRIGGERTHATCANBEDEMONSTRATED.

    http://en.wikipedia.org/wiki/Sinusitishttp://en.wikipedia.org/wiki/Anosmiahttp://en.wikipedia.org/wiki/Infectionhttp://en.wikipedia.org/wiki/Headachehttp://en.wikipedia.org/wiki/Asthmahttp://en.wikipedia.org/wiki/Asthmahttp://en.wikipedia.org/wiki/Headachehttp://en.wikipedia.org/wiki/Infectionhttp://en.wikipedia.org/wiki/Anosmiahttp://en.wikipedia.org/wiki/Sinusitis
  • 7/28/2019 Respiratory Final Presentation

    85/158

    TREATMENT STEROIDSTOPICALOR

    ORAL

    SURGICAL

    METHODS

    .

    FUNCTIONAL ENDOSCOPIC SINUS SURGERY

  • 7/28/2019 Respiratory Final Presentation

    86/158

    FUNCTIONAL ENDOSCOPIC SINUS SURGERY

    PHARYNGITIS

  • 7/28/2019 Respiratory Final Presentation

    87/158

    PHARYNGITIS

    PHARYNGITISISANINFLAMMATIONOFTHE

    PHARYNX, INCLUDINGPALATE,

    TONSILS,ANDPOSTERIORWALL

    OFTHEPHARYNX, MOST

    COMMONLYCAUSEDBYACUTE

    INFECTION, USUALLYTRANSMITTEDTHROUGH

    RESPIRATORYSECETIONS.

    STREPTOCOCCALPHARYNGITIS

    (STREPTHROAT)ANDRHINOVIRUSES (COMMONCOLD)

    AREFREQUENTCAUSES.

    PHARYNGITIS

  • 7/28/2019 Respiratory Final Presentation

    88/158

    PHARYNGITIS

    Acute bacterial pharyngitis is usually caused bygroup A beta-hemolytic streptococci (streptococcalpharyngitis/strep throat).

    Peak age group for streptoccocal pharyngitis is 5 to

    18, but it may occur in all age groups.

    PHARYNGITIS

  • 7/28/2019 Respiratory Final Presentation

    89/158

    PHARYNGITIS

    Other bacterial causes includeH. influenzae,,Corynebacterium diphtheriae (diphtheria),

    Neisseria gonorrhoeae (gonorrhea), and othergroups of streptococcus.

    Transmission ofN. gonorrhoeae is through oralcontact with genital secretions;

    More chronic causes are irritation from postnasal

    drip of allergic rhinitis and chronic sinusitis,chemical irritation, and systemic diseases

    PHARYNGITIS

  • 7/28/2019 Respiratory Final Presentation

    90/158

    PHARYNGITIS

    For acute bacterial infections, abrupt onset of sorethroat and fever (usually above 38.2 0C instreptococcal pharyngitis.

    Throat pain

    Pharynx appears reddened with edema of uvula;pharynx and tonsils may be covered with exudate

    Varying degrees of sore throat, nasal congestion,

    fatigue, and fever with other bacterial and viralcauses.

  • 7/28/2019 Respiratory Final Presentation

    91/158

    DIAGNOSTICS Throat culture or rapid streptococcal antigen

    detection test to rule out streptococci. Rapid streptests provide results within 5 minutes.

    TREATMENT

    ANTIBIOTICS

  • 7/28/2019 Respiratory Final Presentation

    92/158

    Encourage compliance with full course ofantibiotic therapy, despite feeling better in severaldays, to prevent complications.

    Advise lukewarm saline gargles and use

    antipyretic/analgesics as directed to promotecomfort.

    Encourage bed rest with increased fluid intake

    during fever.

    SINUSITIS

  • 7/28/2019 Respiratory Final Presentation

    93/158

    SINUSITIS

    Sinusitis is aninflammation of

    the mucous

    membranes of one

    or more paranasal

    sinuses.

  • 7/28/2019 Respiratory Final Presentation

    94/158

    It is usually precipitated bycongestion from viral upperrespiratory infection and/ornasal allergy.

    Obstruction of the sinus

    ostia (resulting frommucosal swelling and/ormechanical obstructionleads to retention ofsecretions and is the usualprecursor to sinusitis.

  • 7/28/2019 Respiratory Final Presentation

    95/158

    Acute Sinusitis Pain stabbing or aching, over the infected sinus

    and referred to face and head

    Nasal congestion and discharge; may or maynot be present

    Anosmia (lack of smell): inspired or expired aircannot reach the olfactory groove

    Red and edematous nasal mucosa May have fever

  • 7/28/2019 Respiratory Final Presentation

    96/158

    Chronic Sinusitis Persistent nasal obstruction; chronic nasal discharge

    clear or purulent when infected

    Cough produced by constant dripping of dischargeback into nasopharynx

    Feeling of facial fullness/pressure

    Headache may be vague or in same pattern as

    acute sinusitis, more noticeable in the morning;fatigue

  • 7/28/2019 Respiratory Final Presentation

    97/158

    Topical decongestant sprayor drops orsystemic decongestants for mucosal shrinkage toencourage drainage from sinus.

    Topical nasal corticosteroids are frequentlyused in chronic sinusitis, and may be used in acutecases.

    Analgesics pain may be significant

    Warm compresses; cool vapor humidity for comfort and topromote drainage

    LEGIONNAIRES DISEASE

  • 7/28/2019 Respiratory Final Presentation

    98/158

    LEGIONNAIRE S DISEASE

    Causes The bacteria that cause

    Legionnaire's disease have beenfound in water delivery systems.They can survive in thewarm,moist, air conditioning systems

    of large buildings, includinghospitals. Spread of the bacteria from

    person to person has not beenproven.

    Most infections occur in middle-

    aged or older people, although theyhave been reported in children.Typically, the disease is less severein children.

  • 7/28/2019 Respiratory Final Presentation

    99/158

  • 7/28/2019 Respiratory Final Presentation

    100/158

    Symptoms tend to get worseduring the first 4 - 6 days.They typically improve inanother 4 - 5 days.

    Chest pain Coughing up blood Fever Gastrointestinal symptoms,

    such as diarrhea, nausea,vomiting, and abdominalpain

    General discomfort,uneasiness, or ill feeling(malaise)

    Headache Joint pain

    Loss of energy

    Muscle aches andstiffness

    Nonproductive cough

    Shaking chills

    Shortness of breath

    DIAGNOSTICS

    http://www.nlm.nih.gov/medlineplus/ency/article/003089.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003089.htm
  • 7/28/2019 Respiratory Final Presentation

    101/158

    G OS CS

    Tests that may be done include: Arterial blood gases

    Chest x-ray

    Complete blood count (CBC), includingwhite bloodcell count

    Erythrocyte sedimentation rate

    Liver function tests

    Sputum culture for theLegionella bacteria

    INTERVENTIONS

    http://www.nlm.nih.gov/medlineplus/ency/article/003855.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003804.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003642.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003643.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003643.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003638.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003436.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003723.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003723.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003436.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003638.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003643.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003643.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003642.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003804.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003804.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003804.htmhttp://www.nlm.nih.gov/medlineplus/ency/article/003855.htm
  • 7/28/2019 Respiratory Final Presentation

    102/158

    Antibiotics are used to fight the infection. Treatmentis started as soon as Legionnaire's disease issuspected, without waiting for confirmation by labtest.

    Antibiotics commonly used to treat this conditioninclude:

    Quinolones (ciprofloxacin, levofloxacin,

    moxifloxacin, or gatifloxacin) Macrolides (azithromycin, clarithromycin, or

    erythromycin)

  • 7/28/2019 Respiratory Final Presentation

    103/158

    CHEST INJURIES

    RIB FRACTURES

  • 7/28/2019 Respiratory Final Presentation

    104/158

    Rib fracture results fromdirect blunt chesttrauma and causes apotential forintrathoracic injury,

    such as pneumothorax orpulmonary contusion.

    Pain with movementand chest splinting result

    in impaired ventilation andinadequate clearance ofsecretions.

  • 7/28/2019 Respiratory Final Presentation

    105/158

    Pain on inspiration,coughing

    Voluntary splinting,rapid and shallow

    breathing, inhibitedcough, diminished

    breath sounds over area

    Palpable crepitus overarea, bruising

    INTERVENTIONS

  • 7/28/2019 Respiratory Final Presentation

    106/158

    Note that ribs usually unite spontaneously. Position the client in high Fowler's position.

    Administer pain medication as prescribed tomaintain adequate ventilatory status.

    Monitor for increased respiratory distress.

    Instruct the client to self-splint with hands and arms.

    Managed at home

  • 7/28/2019 Respiratory Final Presentation

    107/158

    FLAILCHEST

    Flail chest is blunt chest trauma associated with accidents,

    which may result in hemothorax and rib fractures. The loose segment of the chest wall becomes paradoxical to

    the expansion and contraction of the rest of the chest wall.

  • 7/28/2019 Respiratory Final Presentation

    108/158

    Pain and dyspnea oninspiration

    Paradoxic chestmovement

    Palpable crepitus

    Diminished breathsounds

    > high Fowler's position.

    >humidified oxygen asprescribed.>Encourage coughing anddeep breathing.>Administer painmedication as prescribed.

    >Maintain bed rest and limitactivity to reduce oxygendemands.>Prepare for intubationwith mechanicalventilation, with PEEP for

    severe flail chest associatedwith respiratory failure andshock.

    PULMONARY CONTUSION

  • 7/28/2019 Respiratory Final Presentation

    109/158

    a. Often results from abruptchest compression: ruptureof alveoli and pulmonaryarterioles with hemorrhage

    and interstitial and bronchialedema

    b. May result in airwayobstruction, atelectasis,

    impaired gas diffusionimpacting ability to clearsecretions and breathe

  • 7/28/2019 Respiratory Final Presentation

    110/158

    Manifestations: Appear 12 -24 hours

    after injury

    Increasing shortness ofbreath, restlessness,chest pain

    Copious sputum,

    possibly blood tinged May lead to ARDS,

    death

    Significant pulmonarycontusion can result inlong-term insufficiencyrequiring home healthreferral Client and familyeducation regarding

    care of chronicrespiratory problem

  • 7/28/2019 Respiratory Final Presentation

    111/158

  • 7/28/2019 Respiratory Final Presentation

    112/158

  • 7/28/2019 Respiratory Final Presentation

    113/158

  • 7/28/2019 Respiratory Final Presentation

    114/158

    PNEUMOTHORAX

  • 7/28/2019 Respiratory Final Presentation

    115/158

    a. Pneumothorax is the accumulation of atmospheric air inthe pleural space, which results in a rise in intrathoracic

    pressure and reduced vital capacity.b. The loss of negative intrapleural pressure results in

    collapse of the lung.c. A spontaneous pneumothorax occurs with the rupture

    of a bleb.d. open pneumothorax/secondary pneumothorax

    occurs when an opening through the chest wall allows

    the entrance of positive atmospheric pressure into thepleural space

    e. TENSION PNEUMOTHORAX

  • 7/28/2019 Respiratory Final Presentation

    116/158

    HEMOTHORAX

  • 7/28/2019 Respiratory Final Presentation

    117/158

    Blood in pleural spaceresulting from chesttrauma, surgery,diagnostic procedures

    Blood collection results in

    impaired ventilation andgas exchange, risk ofshock

    Manifestations are

    similar to pneumothorax;diminished lung soundsand dull percussion tone

  • 7/28/2019 Respiratory Final Presentation

    118/158

    Diagnosis is made by chest xray Treatment includes insertion of chest tube; blood

    replacement if significant loss (may be replaced byautotransfusion in which blood collected in chest

    tube and then reinfused within 4 hours as withplanned thoracic surgery)

  • 7/28/2019 Respiratory Final Presentation

    119/158

    Dependent upon severity of problem 1. Small ones: may involve serial xrays to monitor

    resolution without intervention 2. Symptomatic requires insertion of chest tubes

    (thoracostomy)

    Thoracostomy: placement of closed-chest catheter toallow lungs to re-expand

    Pleurodesis - Creation of adhesions between parietaland visceral pleura to prevent recurrent pneumothorax

    ---Instillation of chemical agent (bleomycin, tetracycline,povidone iodine, doxycycline) to cause inflammation andscarring

    Di f th R i t

  • 7/28/2019 Respiratory Final Presentation

    120/158

    Diseases of the Respiratory

    System

    OBSTRUCTIVEAIRWAY DISEASES

    Asthma

  • 7/28/2019 Respiratory Final Presentation

    121/158

    Increased responsiveness of lower airways tomultiple stimuli.

    Episodic and with reversible obstruction.

    May range in severity from mild withoutlimitation of patients activity, to severe andlife-threatening.

    Men and women are equally affected.Afflicts children more commonly than adults.

    ASTHMA

  • 7/28/2019 Respiratory Final Presentation

    122/158

    Asthma is a chronicrespiratory disorder

    Bronchi andbronchioles are

    affected bronchiolemuscles tighten,mucus is produced

    breathing is difficult

    Asthma

  • 7/28/2019 Respiratory Final Presentation

    123/158

    Airway narrowing

    results from: Smooth muscle

    spasm

    Airway edema and

    inflammation

    Mucus plugging

  • 7/28/2019 Respiratory Final Presentation

    124/158

    Variants: Exercise-induced asthma

    Triad asthma nasal polyps, asthma, aspirin intolerance

    Cardiac asthma - An asthmatic attack due to

    bronchoconstriction caused by pulmonary congestionand failure of the left ventricle.

    Asthmatic bronchitis

    Drug-induced asthma Aspirin/NSAIDs

    ASTHMA - causes

  • 7/28/2019 Respiratory Final Presentation

    125/158

    Generally it isthought that asthmais somewhatinherited

    TRIGGERS includepollen, dust, smoke,pets, exercise,exercise, drugs,infectioin

    ASTHMA - symptoms

  • 7/28/2019 Respiratory Final Presentation

    126/158

    Chest tightness

    Wheezing

    Night-time cough

    Restricted breathing

    Labored breathing;flaring nares

    Cough; increasedsecretions

    Distended neck veins Pulsus paradoxus

  • 7/28/2019 Respiratory Final Presentation

    127/158

    INTERVENTIONS

  • 7/28/2019 Respiratory Final Presentation

    128/158

    Assess airway patency.

    Continuously monitorrespiratory status, pulseoximetry, and color; bealert to decreased

    wheezing or a silentchest, which may signalthe inability to move air.

    Prepare the child for achest radiograph.

    Initiate an intravenousline, and prepare tocorrect dehydration,acidosis, or electrolyteimbalances.

    Administer humidifiedoxygen by nasal prongsor face mask.

    Administer quick-relief (rescue)medications.

  • 7/28/2019 Respiratory Final Presentation

    129/158

    1. Quick-Relief (RescueMedications)Short-acting B2-agonists

    Anticholinergics (for relief ofacute bronchospasm)Systemic corticosteroids (for its

    antiinflammatory action to treatreversible airflow obstruction)

    ASTHMA - treatments

  • 7/28/2019 Respiratory Final Presentation

    130/158

    IMMEDIATEbronchodilators give immediate reliefto tightened

    bronchioles

    Inhalers can bemetered - ie medicineis forced out by achemical propellant

    powdered - nopropellant

  • 7/28/2019 Respiratory Final Presentation

    131/158

    2. Long-term control (preventer medications): to achieve

    and maintain control of inflammation

    Leukotriene modifiers to prevent bronchospasm and

    inflammatory cell infiltration

    3. Nebulizer, metered-dose inhaler or peak expiratory flow

    meters

    4. Chest physiotherapy

    5. Allergen control

    Prevention and reduction of exposure to airborne and

    environmental allergens

    Chronic Obstructuve Pulmonary Disease

  • 7/28/2019 Respiratory Final Presentation

    132/158

    FACTORS:

    Cigarette smoking

    Air pollution

    Occupational exposure todusts and gases

    Airway infection

    Genetic and familialfactors

    The Philippine Burden of

    Lung Disease studyindicated that 12 percentor one in eightindividuals 40 years andabove living in MetroManila suffers fromCOPD

    Top eight mortality causein RP

    Affects middle-aged andolder adults

    BRONCHITIS

  • 7/28/2019 Respiratory Final Presentation

    133/158

    An infection of thebronchi

    2 types:

    1. Acute caused by abacteria

    - treated withantibiotics

    CHRONIC BRONCHITIS

  • 7/28/2019 Respiratory Final Presentation

    134/158

    Bronchial Inflamation mucus ciliar.acidosis

    Causes:

    Smoking

    Pollution

    Allergens

    CHRONIC BRONCHITIS

  • 7/28/2019 Respiratory Final Presentation

    135/158

    Assessment:

    1. Chronic Cough

    2. Blue Bloater: cyanotic edema

    chronic cough exertional dyspnea,RR

    hypoxia polycythemia- RBC

    hypercapnia cor pulmonale-RVH &

    resp. acidosis dilatation

    incidence in heavy cigarette smokers

  • 7/28/2019 Respiratory Final Presentation

    136/158

    EMPHYSEMA

  • 7/28/2019 Respiratory Final Presentation

    137/158

    A chronic respiratorydisorder

    The alveolar wallsbreak down & lose

    their elasticity Surface area is

    greatly reduced breathing is difficult

    EMPHYSEMA

  • 7/28/2019 Respiratory Final Presentation

    138/158

    Destruction and Overdistension of the Alveoli

    Air Trapping

    Respi. Acidosis

    Cigarette smokingHeredity, Bronchial asthma Aging process

  • 7/28/2019 Respiratory Final Presentation

    139/158

    Disequilibrium betweenELASTASE & ANTIELASTASE (alpha-1-antitrypsin)

    Destruction of distal airways and alveoli Overdistention of ALVEOLI

    Hyper-inflated and pale lungs

    Air trapping, decreased gas exchange and Retention of CO2

    Hypoxia Respiratory acidosis

    EMPHYSEMA

  • 7/28/2019 Respiratory Final Presentation

    140/158

    CAUSES:

    1. Smoking, Pollution and Allergens

    2. alpha-antitrypsin causes expansion of the

    alveoli

    - strengthens the walls of the

    alveoli(blebs)

    EMPHYSEMA

  • 7/28/2019 Respiratory Final Presentation

    141/158

    Assessment:

    pink puffer:

    mucus speaks in short & jerky sentence

    coughing anxious

    orthopneic pos. Frequently develop URTI

    barrelled chest Prolonged expiratory time

    SOB digital clubbing

    wheezing

    EMPHYSEMA

  • 7/28/2019 Respiratory Final Presentation

    142/158

    ASSESSMENT:

    1. Exertional Dyspnea

    2. Barrelled chest

    3. Hyperesonance

    4. Spontaneous pneumothorax

    EMPHYSEMA - treatments

  • 7/28/2019 Respiratory Final Presentation

    143/158

    Low-flow oxygen tank delivers a higheroxygen concentration

    Lung volumereduction surgery(LVR) removal ofdamaged tissue to lethealthy tissue workmore efficiently

    INTERVENTIONS

  • 7/28/2019 Respiratory Final Presentation

    144/158

    Monitor vital signs.

    Administer a lowconcentration of oxygen (1to 2 L/min) al) prescribed;the stimulus to breathe is alow aeterial P02 instead of

    an increased Pao2 Provide respiratory

    treatments and CPT.

    Instruct the client indiaphragmatic orabdominal and pursed lip

    breathing techniques.

    Suction fluids from the

    client's lungs, if necessary,to clear the airway andprevent infection.

    Monitor weight.

    Encourage small, frequentmeals to prevent dyspnea.

    Provide a high-calorie,high-protein diet withsupplements.

    INTERVENTIONS

  • 7/28/2019 Respiratory Final Presentation

    145/158

    Encourage fluid intake up

    to 3000 mL/day to keepsecretions thin, unlesscontraindicated.

    Position client in highFowler's position and

    leaning forward to aid inbreathing.

    Allow activity as tolerated.

    Administer

    bronchodilators asprescribed, and instruct theclient in the use of oral andinhalant medications.

    Administer corticosteroids

    as prescribed to reduceinflammation.

    Administer mucolytics asprescribed to thinsecretions.

    Administer antibiotics forinfection if prescribed.

    OCCUPATIONAL LUNG DISEASES

  • 7/28/2019 Respiratory Final Presentation

    146/158

    Asbestosis is a diffuse

    interstitial fibrosis of thelung caused by inhalationof asbestos dust andparticles.

    Found in workers involved inmanufacture, cutting and

    demolition of asbestos-containing materials,

    Asbestos mining andmanufacturing, construction,roofing, demolition work,brake linings, floor tiles,paints, plastics, shipyards,insulation

    Fibrous pleural thickening

    and pleural plaqueformation producerestrictive lung disease,decrease in lung volume,diminished gas transfer, andhypoxemia with subsequent

    development of corpulmonale.

    OCCUPATIONAL LUNG DISEASES

  • 7/28/2019 Respiratory Final Presentation

    147/158

    SILICOSIS is a chronic

    pulmonary fibrosis causedby inhalation of silica dust.

    Exposure to silica dust isencountered in almost anyform of mining because the

    earths crust is composed ofsilica and silicates (gold,coal, tin, copper mining);also stone cutting,quarrying, manufacture of

    abrasives, ceramics,pottery, and foundry work.

    When silica particles

    (which have fibrogenicproperties) are inhaled,nodular lesions areproduced througout thelungs. These nodules

    undergo fibrosis, enlarge,and fuse.

    OCCUPATIONAL LUNG DISEASES COAL WORKERS

  • 7/28/2019 Respiratory Final Presentation

    148/158

    COAL WORKERSPNEUMOCONIOSIS

    (CWP; black lung) is a variety

    of respiratory disease found in coalworkers in which there is anaccumulation of coal dust in thelungs, causing a tissue reaction inits presence.

    Dusts (coal, kaolin, mica,silica) are inhaled and deposited

    in the alveoli and respiratorybronchioles.

    When normal clearancemechanisms no longer can handlethe excessive dust load, therespiratory bronchioles and alveolibecome cloged with coal dust,

    dying macrophages, andfibroblasts, which lead to theformation of the coal macule, theprimary lesion of CWP.

    ASSESSMENT

  • 7/28/2019 Respiratory Final Presentation

    149/158

    Chronic cough; productive

    in silicosis and CWP Dyspnea on exertion;

    progressive and irreversiblein asbestosis and CWP

    Susceptibility to lowerrespiratory tract infections

    Bibasilar crackles inasbestosis.

    Expectoration of varyingamounts of black fluid andCWP.

    INTERVENTIONS

  • 7/28/2019 Respiratory Final Presentation

    150/158

    There is no specific treatment; exposure is eliminated,

    and the patient is treated symptomatically. Give prophylactic isoniazid (INH) to patient with positive

    tuberculin test, because silocosis is associated with high risk ofTB

    Persuade people who have been exposed to asbestos fibers tostop smoking to decrease risk of lung cancer.

    Keep asbestosis worker under cancer surveillance; watch forchanging cough, hemoptysis, weight loss, melena, and so

    forth. Bronchodilators may be of some benefit if any degree airway

    obstruction is present

    PNEUMONIA

  • 7/28/2019 Respiratory Final Presentation

    151/158

    The alveoli become

    inflamed and fill withliquid

    Gas exchange isimpaired and the

    body becomesstarved for oxygen

  • 7/28/2019 Respiratory Final Presentation

    152/158

    X-RAY OF PNEUMONIA

  • 7/28/2019 Respiratory Final Presentation

    153/158

    Patient haspneumonia inthe right lung(note white

    mass = fluid)

    Lungs shouldappear black onan x-ray

    Lobular pneumonia

  • 7/28/2019 Respiratory Final Presentation

    154/158

    Lobularpneumoniaaffects a lobeof the lungs(see x-ray),andbronchialpneumoniacan affectpatches

    throughoutboth lungs.

    TYPES OF PNEUMONIA

  • 7/28/2019 Respiratory Final Presentation

    155/158

    LOBULAR BRONCHIAL

    TREATMENT

  • 7/28/2019 Respiratory Final Presentation

    156/158

    BACTERIAL

    Caused by thebacterium

    Streptococcuspneumoniae

    Treated withantibiotics

    Can be somewhatprevented with thepneumococcal

    vaccine

    VIRAL

    Caused by a virus

    Can be treated with

    anti-viral medication They are usually less

    severe however asecondary bacterial

    infection can followwhich is then treatedwith antibiotics

  • 7/28/2019 Respiratory Final Presentation

    157/158

    ASSESSMENT INTERVENTIONS

    Chills

    Elevated temperature

    Pleuritic pain Rhonchi and wheezes

    Use of accessory musclesfor breathing

    Cyanosis Mental status changes

    Sputum production

    Administer oxygen as prescribed. Monitor respiratory status. Monitor for labored respirations,

    cyanosis, and cold and clammy skin. Encourage coughing and deep

    breathing and use of incentivespirometer.

    Position client in semi-Fowlerposition to facilitate breathing andlung expansion.

    Change client's position frequently

    and ambulate as tolerated tomobilize secretions.

    Provide CPT. Perform nasotracheal suctioning if

    the client is unable to clear secretions

  • 7/28/2019 Respiratory Final Presentation

    158/158

    END